Zinc Status and Growth in Infants and Young Children with Cystic Fibrosis

CoughPulmonary Fibrosis

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial

Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT

doi: 10.1016/

Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children

PLoS Pathog.

Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, Ranganathan SC, Boucher RC, Stick SM, Wolfgang MC

doi: 10.1371/

RECOMMENDED

Pulmonary Fibrosis

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Thorax.

Harun SN, Holford NHG, Grimwood K, Wainwright CE, Hennig S, Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group.

doi: 10.1136/

Pulmonary Fibrosis

Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis

Thorax.

Kopp BT, Thompson R, Kim J, Konstan R, Diaz A, Smith B, Shrestha C, Rogers LK, Hayes D Jr, Tumin D, Woodley FW, Ramilo O, Sanders DB, Groner JA, Mejias A

doi: 10.1136/thoraxjnl-

RECOMMENDED

Pulmonary Fibrosis

Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis

★ 1 Recommended by Dr Martin Frey, Faculty Member

doi: 10.1002/ppul.24766.

Pulmonary Fibrosis

Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth

J Cyst Fibros.

Korten I, Kieninger E, Yammine S, Cangiano G, Nyilas S, Anagnostopoulou P, Singer F, Kuehni CE, Regamey N, Frey U, Casaulta C, Spycher BD, Latzin P; SCILD; BILD study group

doi: 10.1016/j.jcf.2018.07.002.

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

Lancet Respir Med.

Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group

doi: 10.1016/S2213-

Pulmonary FibrosisBronchi

Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography

Pediatr Pulmonol.

Kuo W, Soffers T, Andrinopoulou ER, Rosenow T, Ranganathan S, Turkovic L, Stick SM, Tiddens HAWM; AREST CF

doi: 10.1002/ppul.23787.

RECOMMENDED

Pulmonary Fibrosis

Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

Cheney J, Vidmar S, Gailer N, Wainwright C, Douglas TA, Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group.

doi: 10.1016/j.jcf.2020.02.022.

Related content

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial

Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis

Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis

Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography

Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes